Cimetidine
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171901This classification denotes a histamine-2 receptor antagonist with the molecular formula C10H16N6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 80061L1WGD, chemically known as guanidine, n-cyano-n-methyl-n-(2-(((5-methyl-1h-imidazol-4-yl)methyl)thio)ethyl)- but generally known as cimetidine, which bears US NIH Compound Identifier 2756. European Medicines Agency schedules Cimetidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06279MIG. The term CIMETIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). World Health Organization schedules cimetidine in its Anatomical Therapeutic Chemical (ATC) Classification. CIMETIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cimetidine under HS 29332990 and SITC 51573. As of Q4 2014, CIMETIDINE remains the US FDA Preferred Term for this commodity. Cimetidine bears US NLM identifiers UMLS ID C0008783 and NCI Concept Code C374. SMILES: CC1=C(N=CN1)CSCCNC(=NC)NC#N.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.